Filter This View

  • March 17, 2010 | International Edition

    Pharmaceuticals: The game changer

    The pharmaceutical industry is facing uncertain times as a once-lucrative business model buckles under a globalising world economy. Charlotte Edmond reports on the companies and lawyers battling to secure all-important intellectual property in a rapidly changing market

    1 minute read

  • March 17, 2010 |

    White & Case City base posts 20% drop in revenues for 2009

    White & Case's London office has emerged as the worst performing City arm of a US law firm in 2009 - a year in which results varied significantly between firms. White & Case saw London revenues plunge by just under 20% to $197m (£130m) during the 2009 calendar year, with profits per equity partner (PEP) dropping by 11% to $1.32m (£872,000).

    1 minute read

  • March 17, 2010 |

    Pharmaceuticals: The game changer

    The pharmaceutical industry is facing uncertain times as a once-lucrative business model buckles under a globalising world economy. Charlotte Edmond reports on the companies and lawyers battling to secure all-important intellectual property in a rapidly changing market

    1 minute read

  • March 16, 2010 |

    Skadden names new management for Asia-Pacific practice

    Skadden Arps Slate Meagher & Flom has appointed a new co-head of its Asia-Pacific practice. Tokyo partner Audrey Sokoloff has been named as joint head of the group alongside Alan Schiffman, with effect from today (16 March).

    1 minute read

  • March 9, 2010 |

    White & Case makes up five new partners in wake of recent losses

    White & Case has made an additional partner promotions round in a bid to rebuild its partnership following a number of high-profile departures in recent weeks. The US firm has made up five new partners with immediate effect.

    1 minute read

  • March 3, 2010 |

    White & Case rebuilds in London with Skadden restructuring hire

    White & Case has made its first hire in London since the loss of six City partners earlier this year. Skadden Arps Slate Meagher & Flom restructuring lawyer Chris Pilkington will join White & Case as a partner in April, having been at Skadden since October 2004. He was promoted to the rank of senior counsel in May 2008.

    1 minute read

  • March 2, 2010 |

    Skadden heads up trio of firms on $7.2bn Merck acquisition

    A trio of firms have advised on a $7.2bn (£4.8bn) deal that will see German pharma giant Merck acquire lab filter and purifier manufacturer Millipore, reports The Am Law Daily. Skadden took the lead role for Merck, fielding a team including M&A partners Peter Atkins, Hilary Foulkes and Margaret Brown, tax partner Sally Thurston, antitrust partners Frederic Depoortere, Benjamin Crisman and John Lyons, and intellectual property and technology partner Rita Rodin Johnston.

    1 minute read

  • February 26, 2010 |

    Skadden and Cleary take top roles on $12bn Coca-Cola buyout

    Skadden Arps Slate Meagher & Flom has advised Coca-Cola on its $12.2bn (£8bn) deal to acquire the North American operations of its largest bottler, Coca-Cola Enterprises, reports The Am Law Daily. The deal follows PepsiCo's move in August to take control of its two largest bottlers for $7.8bn (£5.1bn).

    1 minute read

  • February 19, 2010 |

    SJ Berwin and Freshfields head up $755m private equity group sale

    SJ Berwin and Freshfields Bruckhaus Deringer have acted on the $755m (£490m) sale of UK private equity group Pantheon, a deal which has also handed roles to a trio of US firms. Freshfields advised acquisitive US money-holding company Affiliated Managers Group (AMG) on its proposed purchase of Pantheon - a private equity fund-of-funds manager - from Russell Investments.

    1 minute read

  • February 15, 2010 |

    Bingham sets standard for London salaries with £100,000 pay for NQs

    Bingham McCutchen has emerged as one of the best-paying firms for newly-qualified (NQ) lawyers in London with NQ salaries of more than £100,000. The firm said that it pays New York rates, which currently stand at around $160,000 (£102,000) for NQs.

    1 minute read